﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2013v3.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2014-11-14T15:40:38-06:00</ReturnTs>
    <TaxPeriodEndDt>2013-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>521855942</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1>TATE AND TRYON</BusinessNameLine1>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1>2021 L STREET NW SUITE 400</AddressLine1>
        <City>WASHINGTON</City>
        <State>DC</State>
        <ZIPCode>20036</ZIPCode>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2013-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>231682043</EIN>
      <BusinessName>
        <BusinessNameLine1>AMERICAN SOCIETY FOR CLINICAL</BusinessNameLine1>
        <BusinessNameLine2>PHARMACOLOGY AND THERAPEUTICS</BusinessNameLine2>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>7038366981</PhoneNum>
      <USAddress>
        <AddressLine1>528 NORTH WASHINGTON STREET</AddressLine1>
        <City>ALEXANDRIA</City>
        <State>VA</State>
        <ZIPCode>22314</ZIPCode>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>SHARON SWAN</PersonNm>
      <PersonTitleTxt>CHIEF EXECUTIVE OFFICER</PersonTitleTxt>
      <PhoneNum>7038366981</PhoneNum>
      <SignatureDt>2014-11-14</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>SUBRINA L WOOD</PreparerPersonNm>
      <PTIN>P00365899</PTIN>
      <PhoneNum>2022932200</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2013</TaxYr>
    <BuildTS>2015-11-30 17:44:51Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="8">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>SHARON SWAN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1>528 NORTH WASHINGTON STREET</AddressLine1>
        <City>ALEXANDRIA</City>
        <State>VA</State>
        <ZIPCode>22314</ZIPCode>
      </USAddress>
      <GrossReceiptsAmt>3369596</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ASCPT.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1900</FormationYr>
      <LegalDomicileStateCd>DC</LegalDomicileStateCd>
      <ActivityOrMissionDesc>ADVANCING THE SCIENCE AND PRACTICE OF CLINICAL PHARMACOLOGY FOR THE THERAPEUTIC BENEFIT OF PATIENTS AND SOCIETY.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>11</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>11</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>9</TotalEmployeeCnt>
      <TotalVolunteersCnt>350</TotalVolunteersCnt>
      <TotalGrossUBIAmt>18265</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>9804</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>113713</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>88684</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>1997339</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>1663807</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>64183</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>42235</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>1044872</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>974103</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>3220107</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>2768829</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>44500</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>27500</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>896295</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>885338</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>2291</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>9350</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>9350</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>2011226</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1744365</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2954312</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2666553</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>265795</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>102276</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>4977245</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>5226153</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>293920</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>251820</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>4683325</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>4974333</NetAssetsOrFundBalancesEOYAmt>
      <MissionDesc>ADVANCING THE SCIENCE AND PRACTICE OF CLINICAL PHARMACOLOGY FOR THE THERAPEUTIC BENEFIT OF PATIENTS AND SOCIETY.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>1196519</ExpenseAmt>
      <GrantAmt>27500</GrantAmt>
      <RevenueAmt>1100093</RevenueAmt>
      <Desc>THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE INDUSTRY, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS FROM AROUND THE WORLD. THERE IS ALSO AN EXHIBIT HALL WITH REPRESENTATIVES FROM VARIOUS COMPANIES.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>872183</ExpenseAmt>
        <Desc>CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. IT CONTINUES TO SEE IMPROVEMENTS IN THE NUMBER OF MANUSCRIPTS RECEIVED AND INCREASES IN SUBSCRIPTIONS.CPT: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (CPT:PSP) IS AN ONLINE, FULLY OPEN ACCESS JOURNAL. CPT:PSP PROVIDES A UNIQUE INTERNATIONAL FORUM FOR SCIENTISTS IN THE PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY SPACE.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>417461</ExpenseAmt>
        <RevenueAmt>563714</RevenueAmt>
        <Desc>MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION TOOLS, SUCH AS THE CPT JOURNAL, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>2486163</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="RetDoc1039600001">0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="RetDoc1039600001">0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="RetDoc1039600001">0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">1</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">1</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>27</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>9</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>1</Form990TFiledInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>11</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>11</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>1</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>1</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1>THE SOCIETY</BusinessNameLine1>
        </BusinessName>
        <PhoneNum>7038366981</PhoneNum>
        <USAddress>
          <AddressLine1>528 NORTH WASHINGTON STREET</AddressLine1>
          <City>ALEXANDRIA</City>
          <State>VA</State>
          <ZIPCode>22314</ZIPCode>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>RUSS ALTMAN MD PHD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KATHLEEN M GIACOMINI PHD</PersonNm>
        <TitleTxt>IMMEDIATE PAST PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GREGORY L KEARNS PHARMDPHD</PersonNm>
        <TitleTxt>SECRETARY TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANDREA GAEDIGKMS PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DHANESH K GUPTA MD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MALLE JURIMA-ROMET PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES J KEIRNS PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SASKIA DE WILDT MD PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KEITH D WILNER PHD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNE ZAJICEK MD PHARMD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SHARON J SWAN</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>359660</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>39749</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>359660</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>39749</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1>FREEMAN AUDIO VISUAL SOLUTIONS INC</BusinessNameLine1>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1>PO BOX 650519</AddressLine1>
            <City>DALLAS</City>
            <State>TX</State>
            <ZIPCode>752650519</ZIPCode>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>AUDIO VISUAL SERVICES</ServicesDesc>
        <CompensationAmt>228654</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>88684</AllOtherContributionsAmt>
      <TotalContributionsAmt>88684</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>REGISTRATION FEES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>783051</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>783051</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MEMBERSHIP DUES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>563714</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>563714</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>EXHIBITS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>187950</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>187950</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>AM SPONSORSHIPS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>129092</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>129092</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>1663807</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>81148</TotalRevenueColumnAmt>
        <ExclusionAmt>81148</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>972218</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>18265</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>953953</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>561854</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>600767</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>-38913</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>-38913</TotalRevenueColumnAmt>
        <ExclusionAmt>-38913</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1885</TotalRevenueColumnAmt>
        <ExclusionAmt>1885</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>1885</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>2768829</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1663807</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>18265</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>998073</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>27500</TotalAmt>
        <ProgramServicesAmt>27500</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>400412</TotalAmt>
        <ProgramServicesAmt>294824</ProgramServicesAmt>
        <ManagementAndGeneralAmt>105588</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>402681</TotalAmt>
        <ProgramServicesAmt>323412</ProgramServicesAmt>
        <ManagementAndGeneralAmt>79269</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>18434</TotalAmt>
        <ManagementAndGeneralAmt>18434</ManagementAndGeneralAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>18883</TotalAmt>
        <ProgramServicesAmt>14526</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4357</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>44928</TotalAmt>
        <ProgramServicesAmt>36144</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8784</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>21130</TotalAmt>
        <ManagementAndGeneralAmt>21130</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>87237</TotalAmt>
        <ManagementAndGeneralAmt>87237</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>9350</TotalAmt>
        <FundraisingAmt>9350</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>17366</TotalAmt>
        <ManagementAndGeneralAmt>17366</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>221737</TotalAmt>
        <ProgramServicesAmt>189096</ProgramServicesAmt>
        <ManagementAndGeneralAmt>32641</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>100506</TotalAmt>
        <ProgramServicesAmt>39508</ProgramServicesAmt>
        <ManagementAndGeneralAmt>60998</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>5667</TotalAmt>
        <ManagementAndGeneralAmt>5667</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>39940</TotalAmt>
        <ManagementAndGeneralAmt>39940</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>31729</TotalAmt>
        <ProgramServicesAmt>16884</ProgramServicesAmt>
        <ManagementAndGeneralAmt>14845</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>687024</TotalAmt>
        <ProgramServicesAmt>646149</ProgramServicesAmt>
        <ManagementAndGeneralAmt>40875</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>56964</TotalAmt>
        <ManagementAndGeneralAmt>56964</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>16521</TotalAmt>
        <ManagementAndGeneralAmt>16521</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>UBIT TAX</Desc>
        <TotalAmt>3058</TotalAmt>
        <ProgramServicesAmt>3058</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>AWARDS/HONORARIUM</Desc>
        <TotalAmt>193539</TotalAmt>
        <ProgramServicesAmt>180061</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13478</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CPT SUBSCRIPTIONS</Desc>
        <TotalAmt>79933</TotalAmt>
        <ProgramServicesAmt>79933</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>EDITORIAL EXPENSES</Desc>
        <TotalAmt>55011</TotalAmt>
        <ProgramServicesAmt>55011</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>127003</TotalAmt>
        <ProgramServicesAmt>580057</ProgramServicesAmt>
        <ManagementAndGeneralAmt>-453054</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2666553</TotalAmt>
        <ProgramServicesAmt>2486163</ProgramServicesAmt>
        <ManagementAndGeneralAmt>171040</ManagementAndGeneralAmt>
        <FundraisingAmt>9350</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1286542</BOYAmt>
        <EOYAmt>1519042</EOYAmt>
      </CashNonInterestBearingGrp>
      <LandBldgEquipCostOrOtherBssAmt>1107931</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>317743</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>797467</BOYAmt>
        <EOYAmt>790188</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>2277090</BOYAmt>
        <EOYAmt>2322652</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>616146</BOYAmt>
        <EOYAmt>594271</EOYAmt>
      </IntangibleAssetsGrp>
      <TotalAssetsGrp>
        <BOYAmt>4977245</BOYAmt>
        <EOYAmt>5226153</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>26352</BOYAmt>
        <EOYAmt>31083</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>267568</BOYAmt>
        <EOYAmt>220737</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>293920</BOYAmt>
        <EOYAmt>251820</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>4444541</BOYAmt>
        <EOYAmt>4717257</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>238784</BOYAmt>
        <EOYAmt>257076</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>4683325</BOYAmt>
        <EOYAmt>4974333</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>4977245</BOYAmt>
        <EOYAmt>5226153</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>102276</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>188732</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingOtherInd methodOfAccountingOtherDesc="modified cash">X</MethodOfAccountingOtherInd>
      <AccountantCompileOrReviewInd>1</AccountantCompileOrReviewInd>
      <AcctCompileOrReviewBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </AcctCompileOrReviewBasisGrp>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>785856</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>790550</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>780211</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>727314</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>652399</CurrentTaxYearAmt>
        <TotalAmt>3736330</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>785856</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>790550</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>780211</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>727314</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>652399</CurrentTaxYearAmt>
        <TotalAmt>3736330</TotalAmt>
      </TotalCalendarYear170Grp>
      <PublicSupportTotal170Amt>3736330</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>695023</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>995716</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>854059</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1074743</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1041798</CurrentTaxYearAmt>
        <TotalAmt>4661339</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <CurrentTaxYearMinus3YearsAmt>13429</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>11067</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>14358</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>14302</CurrentTaxYearAmt>
        <TotalAmt>53156</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>8451</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>12250</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>6537</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>18301</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1885</CurrentTaxYearAmt>
        <TotalAmt>47424</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>8498249</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>5758231</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.43970</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.45810</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="RetDoc1039600001">
      <TotalLobbyingExpendGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotalLobbyingExpendGrp>
      <OtherExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>2636279</FilingOrganizationsTotalAmt>
      </OtherExemptPurposeExpendGrp>
      <TotalExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>2636279</FilingOrganizationsTotalAmt>
      </TotalExemptPurposeExpendGrp>
      <LobbyingNontaxableAmountGrp>
        <FilingOrganizationsTotalAmt>281814</FilingOrganizationsTotalAmt>
      </LobbyingNontaxableAmountGrp>
      <GrassrootsNontaxableGrp>
        <FilingOrganizationsTotalAmt>70454</FilingOrganizationsTotalAmt>
      </GrassrootsNontaxableGrp>
      <TotLbbyngGrassrootMnsNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyngGrassrootMnsNonTxGrp>
      <TotLbbyExpendMnsLbbyngNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyExpendMnsLbbyngNonTxGrp>
      <AvgLobbyingNontaxableAmountGrp>
        <CurrentYearMinus3Amt>279315</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>279172</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>296968</CurrentYearMinus1Amt>
        <CurrentYearAmt>281814</CurrentYearAmt>
        <TotalAmt>1137269</TotalAmt>
      </AvgLobbyingNontaxableAmountGrp>
      <LobbyingCeilingAmt>1705904</LobbyingCeilingAmt>
      <AvgGrassrootsNontaxableGrp>
        <CurrentYearMinus3Amt>69829</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>69793</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>74242</CurrentYearMinus1Amt>
        <CurrentYearAmt>70454</CurrentYearAmt>
        <TotalAmt>284318</TotalAmt>
      </AvgGrassrootsNontaxableGrp>
      <GrassrootsCeilingAmt>426477</GrassrootsCeilingAmt>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>411569</BeginningYearBalanceAmt>
        <ContributionsAmt>60083</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>45311</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>42119</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>3765</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>471079</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>427130</BeginningYearBalanceAmt>
        <ContributionsAmt>59572</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>29502</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>101627</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>3008</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>411569</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>400285</BeginningYearBalanceAmt>
        <ContributionsAmt>56125</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>6360</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>32767</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>2873</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>427130</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>283468</BeginningYearBalanceAmt>
        <ContributionsAmt>104917</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>27665</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>13518</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>2247</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>400285</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>245922</BeginningYearBalanceAmt>
        <ContributionsAmt>8001</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>37775</InvestmentEarningsOrLossesAmt>
        <AdministrativeExpensesAmt>8230</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>283468</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.54570</BoardDesignatedBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.45430</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <LandGrp>
        <OtherCostOrOtherBasisAmt>186000</OtherCostOrOtherBasisAmt>
        <BookValueAmt>186000</BookValueAmt>
      </LandGrp>
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>577816</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>149269</DepreciationAmt>
        <BookValueAmt>428547</BookValueAmt>
      </BuildingsGrp>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>195657</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>47588</DepreciationAmt>
        <BookValueAmt>148069</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>123338</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>97544</DepreciationAmt>
        <BookValueAmt>25794</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>25120</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>23342</DepreciationAmt>
        <BookValueAmt>1778</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>790188</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>CORPORATE BONDS</Desc>
        <BookValueAmt>742090</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>EQUITIES &amp; MUTUAL FUNDS</Desc>
        <BookValueAmt>1580562</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>2322652</TotalBookValueSecuritiesAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>2957560</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>188731</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>188731</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>2768829</RevenueSubtotalAmt>
      <RevenueNotReportedFinclStmtAmt>0</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>2768829</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2666553</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2666553</ExpensesSubtotalAmt>
      <ExpensesNotRptFinclStmtAmt>0</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>2666553</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>PURPOSE OF ENDOWMENT: THE BOARD OF DIRECTORS HAS DESIGNATED CASH AND INVESTMENTS TO BE SET ASIDE TO MEET AT LEAST THREE MONTHS WORTH OF OPERATING EXPENSES. THE BOARD HAS ALSO DESIGNATED CERTAIN INVESTMENTS AND THE INCOME RELATED TO THOSE INVESTMENTS ACCOUNTS FOR PAYMENT OF THE SOCIETY'S AWARD PROGRAMS AT ITS ANNUAL MEETING. THE AWARDS PROGRAM FOR WHICH INVESTMENTS HAVE BEEN SET ASIDE INCLUDE THE WILLIAM B. ABRAMS AWARD, THE RAWLS-PALMER AWARD, AND THE SCIENTIFIC AWARDS COMMITTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY HAS EVALUATED ITS TAX POSITIONS FOR ALL OPEN TAX YEARS. CURRENTLY, THE TAX YEARS OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE ARE THE 2011, 2012, AND 2013 TAX YEARS. HOWEVER, THE SOCIETY IS NOT CURRENTLY UNDER AUDIT. BASED ON THE EVALUATION OF THE SOCIETYS TAX POSITIONS, MANAGEMENT BELIEVES ALL TAX POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISIONS FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAVE BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2013.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>0</GrantRecordsMaintainedInd>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>FDA ABRAMS AWARD LECTURE</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>GARY NEIL PRIZE</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>2500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>SHEINER-BEAL PHARMACOMETRICS AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>RAWLS-PALMER AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>WILLIAM B. ABRAMS AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>HENRY W. ELLIOT DISTINGUISHED SERVICE AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>LEON I. GOLDBERG YOUNG INVESTIGATOR AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>OSCAR B. HUNTER MEMORIAL AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>ASCPT YOUNG INVESTIGATOR AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>17500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SHARON J SWAN</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>311163</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>44647</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>3850</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>33000</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>7752</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>400412</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY HAS TWO CLASSES OF MEMBERS: FULL MEMBER AND TRAINEE/STUDENT MEMBER FULL MEMBER: FOR APPLICANTS WHO HAVE EARNED A DOCTORATE DEGREE OR EQUIVALENT IN ANY OF THE BIOMEDICAL SCIENCES. ALSO FOR APPLICANTS IN EXECUTIVE AND LEADERSHIP ROLES IN RELATED ORGANIZATIONS. APPLICANTS MUST DEMONSTRATE A SINCERE INTEREST IN, AND CONTRIBUTIONS TO, HUMAN PHARMACOLOGY AND THERAPEUTICS THROUGH PUBLICATIONS, GRANTS, PATENTS, GOVERNMENTAL REPORTS, COMPANY REPORTS, ETC. TRAINEE/STUDENT MEMBER: FOR APPLICANTS CURRENTLY ENROLLED IN A POST-DOCTORAL TRAINING PROGRAM WHO HAVE DEMONSTRATED AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS. ALSO FOR APPLICANTS WHO ARE PURSUING A POST-BACCALAUREATE DEGREE AND WHO POSSESS AN INTEREST IN HUMAN PHARMACOLOGY AND THERAPEUTICS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>MEMBERS SHALL HAVE SUCH VOTING PRIVILEGES AS ARE DETERMINED FROM TIME TO TIME BY THE SOCIETY'S GOVERNING BOARD AND SHALL VOTE IN SUCH MANNER AS DETERMINED BY THE GOVERNING BOARD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7B</FormAndLineReferenceDesc>
        <ExplanationTxt>ANY CHANGES TO THE ORGANIZATION'S BYLAWS ARE SUBJECT TO APPROVAL BY THE FULL MEMBERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FORM 990 IS REVIEWED BY THE ASCPT EXECUTIVE DIRECTOR AND ASCPT LEGAL COUNSEL FOLLOWING PREPARATION BY THE SOCIETY'S ACCOUNTANTS. THE OFFICERS OF ASCPT REVIEW THE DOCUMENT PRIOR TO IT BEING FILED. THE BOARD IS INFORMED ABOUT THE PREPARATION AND FILING OF THE FORM 990 AND THE RETURN IS MADE AVAILABLE AT ANY TIME TO ANY BOARD MEMBER FOR THEIR REVIEW.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THROUGH WRITTEN DISCLOSURES TO LEGAL COUNSEL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY THE ASCPT COMPENSATION COMMITTEE USING COMPARABILITY DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE EXECUTIVE DIRECTOR USING COMPARABILITY DATA.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE ASCPT WEB SITE. FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 24E</FormAndLineReferenceDesc>
        <ExplanationTxt>BANK &amp; CREDIT CARD FEES: PROGRAM SERVICE EXPENSES 46,925. MANAGEMENT AND GENERAL EXPENSES 1,934. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 48,859. STRATEGIC PLAN: PROGRAM SERVICE EXPENSES 18,741. MANAGEMENT AND GENERAL EXPENSES 10,721. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 29,462. MISCELLANEOUS: PROGRAM SERVICE EXPENSES 18,329. MANAGEMENT AND GENERAL EXPENSES 10,270. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 28,599. TRAINING: PROGRAM SERVICE EXPENSES 2,974. MANAGEMENT AND GENERAL EXPENSES 16,639. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 19,613. TEMPORARY HELP: PROGRAM SERVICE EXPENSES 470. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 470.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 1:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQIUPMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AUDIT OVERSIGHT PROCESS REMAINS UNCHANGED FROM THE PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>